Precision Plant Molecules (PPM) coined the term Cannamimetics to describe naturally inspired ways to access important, bioactive “minor” cannabinoids that currently manifest in existing hemp cultivars in de minimis concentrations. More effective plant-based extracts and concentrates can be formulated with these cannabinoids.
Digital Science launched a report on the state of open access monographs. The report addresses the question of how the company integrates and values monographs in the increasingly open digital scholarly network.
Through consultation with physicians and patients, the Canadian Breast Cancer Network (CBCN) outlined five key recommendations for consideration when implementing biosimilars in oncology
White Paper: Safety Profile of the Analgesic Trezix™ Capsules, Containing the Mild Opioid Dihydrocodeine
Privately held pharmaceutical company Wraser Pharmaceuticals announced the publication of a White Paper addressing opioid safety.
Although biosimilars have not had the immediate uptake in the United States that they have had in Europe, health plans expect these products will become a staple of therapy for some diseases by 2020 – if the price is right.
The white paper from moddern marketing provides five core principles to help ASC owners and investors understand marketing and healthcare consumers. NEW YORK (PRWEB) February 11, 2019 moddern marketing (moddern), an award-winning independently-owned integrated marketing agency, has released a White Paper for ambulatory surgical center (ASC) owners and investors entitled “Building a Thriving […]
A white paper by Health Strategies Group, an Eversana company, which is the leading independent provider of global services to the life sciences industry.
This whitepaper assesses the current state of the large molecule sector, and how it may be able to learn from the small molecule industry in terms of its supply chain support infrastructure, as well as its acquisition of staff and the adoption of PAT.
The American Health Policy Institute (AHPI) released “’Tipping Points’ of Employer-Sponsored Health Insurance,” which examines various factors that could impact broad-based employer-provided health coverage.
The American College of Rheumatology published a new white paper, “The Science Behind Biosimilars – Entering a New Era of Biologic Therapy,” providing a comprehensive overview of the scientific, clinical, economic and prescribing issues pertaining to biosimilar use, including efficacy, competition and drug pricing.